Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1992American Journal of Hypertension

Reversal of Left Ventricular Hypertrophy in Hypertensive Patients

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Do different classes of antihypertensive therapies reduce left ventricular mass in hypertensive patients?

Population

2,357 hypertensive patients from 109 studies, average age 49 years (range 30 to 71), 28% previously untreated.

Comparison

Antihypertensive pharmacologic therapy vs Comparison between different classes of…

Design

Meta-analysis

Authors

Björn DahlöfBjörn DahlöfPreventive CardiologyKPKjell PennertRoyal Marsden NHS Foundation TrustLHLennart HanssonUppsala University

Discussion

Loading...

Member takes

Implication

ACE inhibitors may be prioritized for LVH regression; extends class-comparison evidence with quantified LVM reductions.

Structured PICO

Do different classes of antihypertensive therapies reduce left ventricular mass in hypertensive patients?

P
Population
2,357 hypertensive patients from 109 studies, average age 49 years (range 30 to 71), 28% previously untreated.
I
Intervention
Antihypertensive pharmacologic therapy (ACE inhibitors, beta-blockers, calcium antagonists, or diuretics)
C
Comparator
Comparison between different classes of first-line antihypertensive therapies
O
Outcome
Left ventricular mass (LVM) measured by echocardiographysurrogate

ACE inhibitors appear more effective than other first-line antihypertensive therapies in reversing left ventricular hypertrophy, primarily by reducing wall thickness.

Cite This Study

Dahlöf et al. (1992) studied this question.

synapsesocial.com/papers/69effa50bce9831ba4f73aechttps://doi.org/10.1093/ajh/5.2.95

Topics

Hypertension managementEchocardiography
View Full Paper
Ask AI
Bookmark
Share